ABSTRACT
For the long-term efficacy of dry eye disease treatment, relieving underlying inflammation is necessary. Imatinib mesylate is a novel ophthalmic formulation of imatinib mesylate, which is expected to alleviate inflammation by inhibiting the discoidin domain receptor 1 activity. This study aims to evaluate the safety and pharmacokinetics of imatinib mesylate in healthy subjects. A randomized, double-blind, placebo-controlled study was conducted. In a single ascending dose, 16 subjects received a single eye drop of imatinib mesylate 0.1%, 0.3%, or matching placebo. In the multiple ascending dose (MAD), subjects received multiple eye drops of imatinib mesylate 0.1%, 0.3%, or matching placebo once daily for 7 days. Safety and tolerability were assessed by ophthalmic examination, including the visual analog scale (VAS) to monitor the burning sensation in the eyes. A total of four treatment-emergent adverse events (TEAEs) occurred during the study. All TEAEs were mildly severe with no serious cases. VAS results in the 0.1% MAD group exhibited highest score of two points, whereas it was less than one point in others. Insignificant difference between the imatinib mesylate and placebo groups in the VAS results was seen. After a single dose administration of imatinib mesylate 0.1%, all plasma concentrations were below the lower limit of quantification. The peak plasma concentrations of imatinib were less than 0.54 µg/L in all groups. In conclusion, a single and multiple topical ophthalmic administration of imatinib mesylate was well-tolerated in healthy subjects. Because there was minimal systemic exposure to imatinib, the adverse effect in the body seems to be insignificant.
Subject(s)
Inflammation , Administration, Ophthalmic , Dose-Response Relationship, Drug , Double-Blind Method , Healthy Volunteers , Humans , Imatinib Mesylate/adverse effects , Ophthalmic Solutions/adverse effectsABSTRACT
It has been shown previously that a novel tetrapeptide, Arg-Leu-Tyr-Glu (RLYE), derived from human plasminogen inhibits vascular endothelial growth factor (VEGF)-induced angiogenesis, suppresses choroidal neovascularization in mice by an inhibition of VEGF receptor-2 (VEGFR-2) specific signaling pathway. In this study, we report that a modified tetrapeptide (Ac-RLYE) showed improved anti-choroidal neovascularization (CNV) efficacy in a number of animal models of neovascular age-related macular degeneration (AMD) which include rat, rabbit, and minipig. The preventive and therapeutic in vivo efficacy of Ac-RLYE via following intravitreal administration was determined to be either similar or superior to that of ranibizumab and aflibercept. Assessment of the intraocular pharmacokinetic and toxicokinetic properties of Ac-RLYE in rabbits demonstrated that it rapidly reached the retina with minimal systemic exposure after a single intravitreal dose, and it did not accumulate in plasma during repetitive dosing (bi-weekly for 14 weeks). Our results suggested that Ac-RLYE has a great potential for an alternative therapeutics for neovascular (wet) AMD. Since the amino acids in human VEGFR-2 targeted by Ac-RLYE are conserved among the animals employed in this study, the therapeutic efficacies of Ac-RLYE evaluated in those animals are predicted to be observed in human patients suffering from retinal degenerative diseases.
Subject(s)
Macular Degeneration/etiology , Macular Degeneration/metabolism , Oligopeptides/pharmacology , Acetylation , Animals , Choroidal Neovascularization/drug therapy , Choroidal Neovascularization/metabolism , Choroidal Neovascularization/pathology , Disease Models, Animal , Disease Susceptibility , Fluorescein Angiography , Humans , Macular Degeneration/diagnosis , Macular Degeneration/drug therapy , Male , Mice , Oligopeptides/chemistry , Promoter Regions, Genetic , Rabbits , Ranibizumab/pharmacology , Receptors, Vascular Endothelial Growth Factor , Recombinant Fusion Proteins/pharmacology , Retina/metabolism , Retina/pathology , Retinal Neovascularization/drug therapy , Retinal Neovascularization/metabolism , Retinal Neovascularization/pathology , Swine , Treatment Outcome , Vascular Endothelial Growth Factor A/chemistry , Vascular Endothelial Growth Factor A/metabolismABSTRACT
The Korean herbal formulation Ojayeonjonghwan is used for improving late-onset hypogonadism (LOH) symptoms such as erectile dysfunction (ED). A previous research suggested that a modified Ojayeonjonghwan (KH-204) could be used as an alternative to the treatment for ED. The pharmacological effects were examined in different conditions, including in vitro and in vivo. We measured the survival rate of TM3 Leydig cells under the oxidative stress condition. The s.c. injection of leuprorelin was used to induce androgen deprivation. We measured serum testosterone levels, oxidative stress, and apoptosis. The results of the treatment by KH-204 (1) preserved TM3 cells from oxidative stress by improving the expression of nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1); (2) lowered the expression of transforming growth factor-beta (TGF-ß) 1/SMAD; (3) increased the average of serum testosterone in androgen-deprived male rats; (4) kept the activation of spermatogenesis; (5) upgraded the contents of 8-hydroxy-20-deoxyguanosine (8-OHdG) and degraded the contents of superoxide dismutase (SOD); and (6) reduced apoptosis. We studied that KH-204 improved testicular dysfunction in LOH. It is likely, at least in part, to degrade oxidative stress through the Nrf2/HO-1 pathway. These findings may offer credible evidences for the use of new alternative therapies to treat LOH.
Subject(s)
Andropause/physiology , Antioxidants/metabolism , Heme Oxygenase-1/metabolism , Herbal Medicine/methods , NF-E2-Related Factor 2/metabolism , Animals , Male , Rats , Rats, Sprague-Dawley , Signal TransductionABSTRACT
We evaluated the effects of Seoritae extract (SE) on mild to moderate lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Seventy-six subjects with mild to moderate LUTS suggestive of BPH were prospectively recruited from the urology outpatient clinic and assigned to either SE (4200 mg or 6 tablets 3 times a day) or matching placebo. The primary outcome variable, the International Prostatic Symptom Score (IPSS), was evaluated at baseline and at 4 and 12 weeks. Postvoid residual volume (PVR), maximum urine flow rate (Q max), and prostate-specific antigen (PSA) levels were evaluated. IPSSs decreased significantly from baseline to 12 weeks within the SE group. Significant improvements in IPSS voiding scores at 4 and 12 weeks were also observed in the SE group compared to the placebo group. IPSS storage and quality of life scores were also significantly decreased at 12 weeks in the SE group. There was no change in Q max or PVR in both groups after 12 weeks. Administration of SE for 12 weeks led to significant improvements in LUTS, and it can be concerned as a reasonable and safe alternative for men with mild to moderate LUTS.
ABSTRACT
Human amniotic membrane-derived mesenchymal stem cells (hAM-MSCs) are capable of differentiating into several lineages and possess immunomodulatory properties. In this study, we investigated the soluble factor-mediated immunomodulatory effects of hAM-MSCs. Mitogen-induced peripheral blood mononuclear cell (PBMC) proliferation was suppressed by hAM-MSCs in a dose-dependent manner as well as hAM-MSC culture supernatant. Moreover, interferon-gamma and interleukin (IL)-17 production significantly decreased from PBMC, whereas IL-10 from PBMCs and transforming growth factor beta (TGF-ß) production from hAM-MSCs significantly increased in co-cultures of hAM-MSCs and PBMCs. Production of several MSC factors, including hepatocyte growth factor (HGF), TGF-ß, prostaglandin E2 (PGE2), and indoleamine 2, 3 dioxygenase (IDO), increased significantly in hAM-MSCs co-cultured with PBMCs. These results indicate that the immunomodulatory effects of hAM-MSCs may be associated with soluble factors (TGF-ß, HGF, PGE2, and IDO), suggesting that hAM-MSCs may have potential clinical use in regenerative medicine.
Subject(s)
Amnion/immunology , Immunologic Factors/immunology , Mesenchymal Stem Cells/immunology , Amnion/cytology , Cell Differentiation/immunology , Coculture Techniques , Dinoprostone/genetics , Dinoprostone/immunology , Female , Hepatocyte Growth Factor/genetics , Hepatocyte Growth Factor/immunology , Humans , Immunophenotyping , Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics , Indoleamine-Pyrrole 2,3,-Dioxygenase/immunology , Interferon-gamma/immunology , Interleukin-10/analysis , Interleukin-10/immunology , Interleukin-17/analysis , Interleukin-17/immunology , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/immunology , Mesenchymal Stem Cells/cytology , Pregnancy , RNA, Messenger/chemistry , RNA, Messenger/genetics , Regenerative Medicine/methods , Reverse Transcriptase Polymerase Chain Reaction , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/immunologyABSTRACT
The Staphylococcus (S.) intermedius group (SIG) has been a main research subject in recent years. S. pseudintermedius causes pyoderma and otitis in companion animals as well as foodborne diseases. To prevent SIG-associated infection and disease outbreaks, identification of both staphylococcal exotoxins and staphylococcal cassette chromosome mec (SCCmec) types among SIG isolates may be helpful. In this study, it was found that a single isolate (one out of 178 SIG isolates examined) harbored the canine enterotoxin SEC gene. However, the S. intermedius exfoliative toxin gene was found in 166 SIG isolates although the S. aureus-derived exfoliative toxin genes, such as eta, etb and etd, were not detected. SCCmec typing resulted in classifying one isolate as SCCmec type IV, 41 isolates as type V (including three S. intermedius isolates), and 10 isolates as non-classifiable. Genetic relatedness of all S. pseudintermedius isolates recovered from veterinary staff, companion animals, and hospital environments was determined by pulsed-field gel electrophoresis. Strains having the same band patterns were detected in S. pseudintermedius isolates collected at 13 and 18 months, suggesting possible colonization and/or expansion of a specific S. pseudintermedius strain in a veterinary hospital.
Subject(s)
Cat Diseases/microbiology , Dog Diseases/microbiology , Exotoxins/genetics , Staphylococcal Infections/veterinary , Staphylococcus intermedius/genetics , Staphylococcus intermedius/isolation & purification , Animals , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Cat Diseases/epidemiology , Cats , Chromosomes, Bacterial/genetics , Chromosomes, Bacterial/metabolism , Dog Diseases/epidemiology , Dogs , Electrophoresis, Gel, Pulsed-Field/veterinary , Enterotoxins/genetics , Enterotoxins/metabolism , Exfoliatins/genetics , Exfoliatins/metabolism , Exotoxins/metabolism , Hospitals, Animal , Humans , Medical Staff, Hospital , Molecular Sequence Data , Pets/microbiology , Polymerase Chain Reaction/veterinary , Republic of Korea/epidemiology , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus/genetics , Staphylococcus/isolation & purificationABSTRACT
Infectious upper respiratory disease (IURD) of Thoroughbred racehorses has been a frequent problem (29.6% of incidence) at the Seoul Race Park (Korea). Risk factors for IURD include the season with a high transfer rate (summer and fall), the stabling period (≤ 3 months), and age (2 to 3 years old), suggesting that the movement and new environment may have depressed the immune system of the horses and decreased their ability to respond properly to pathogens. The bacterial strains (n = 98) isolated from IURD horses included Pseudomonas spp., Escherichia coli, Staphylococcus spp., Streptococcus equi subsp. equi and zooepidemicus.
Subject(s)
Bacteria/isolation & purification , Bacterial Infections/veterinary , Horse Diseases/microbiology , Respiratory Tract Infections/veterinary , Animals , Bacterial Infections/epidemiology , Bacterial Infections/immunology , Bacterial Infections/microbiology , Horse Diseases/epidemiology , Horse Diseases/immunology , Horses , Incidence , Microbial Sensitivity Tests , Republic of Korea/epidemiology , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/immunology , Respiratory Tract Infections/microbiology , Risk FactorsABSTRACT
The Staphylococcus intermedius bacterial group (SIG) includes 3 distinct genetically heterogenous species: S. intermedius, S. pseudintermedius, and S. delphini. This pathogen group is associated with many opportunistic skin and ear infections in companion animals. Human infections with S. intermedius and S. pseudintermedius isolates and the emergence of methicillin-resistant isolates have been recently reported, which emphasizes the importance of nationwide identification of SIG isolate prevalence and antibiotic resistance in veterinary clinics. In the present study, a total of 178 SIG isolates were obtained from veterinary staff (n â=â 40), companion animals (n â=â 115), and the local environment (n â=â 23) in 8 Korean veterinary hospitals. Isolates were differentiated into 167 S. pseudintermedius (93.8%) and 11 S. intermedius (6.2%) isolates; S. delphini isolates were not identified. The most effective antibiotics against these isolates included amoxicillin-clavulanic acid, amikacin, nitrofloxacin, imipenem, and vancomycin; whereas ampicillin, penicillin, tetracycline, erythromycin, and trimethoprim-sulfamethoxazole were not effective. Surprisingly, the 128 SIG isolates (71.9%) displayed multiple drug resistance (MDR) against 3 or more antibiotic classes. Out of 52 SIG isolates carrying the methicillin-resistance gene (mecA), only 34 (65.4%) were oxacillin-resistant, and 49 (94.2%) methicillin-resistant SIG were multidrug resistant. This finding suggests the presence of greater numbers of MDR phenotypes than other isolates (P < 0.05).
Subject(s)
Cat Diseases/microbiology , Dog Diseases/microbiology , Pets/microbiology , Staphylococcal Infections/veterinary , Staphylococcus intermedius/isolation & purification , Zoonoses/microbiology , Animals , Cat Diseases/epidemiology , Cats , Chi-Square Distribution , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Dog Diseases/epidemiology , Dogs , Drug Resistance, Multiple, Bacterial , Hospitals, Animal , Humans , Korea/epidemiology , Microbial Sensitivity Tests/veterinary , Polymerase Chain Reaction/veterinary , Prevalence , Staphylococcal Infections/microbiology , Staphylococcus intermedius/genetics , Zoonoses/epidemiologyABSTRACT
The antibiotic resistance patterns and prevalence of the transferable tet(O) plasmid were investigated in Campylobacter jejuni and Campylobacter coli isolates from raw chicken, pork, and humans with clinical campylobacteriosis. A total of 180 C. jejuni and C. coli isolates were identified, and the prevalence rates of C. jejuni and C. coli in raw chicken samples were 83% (83 of 100) and 73% (73 of 100), respectively. Twelve percent (6 of 50) and 10% (5 of 50) of pork samples were contaminated with C. jejuni and C. coli, respectively. Disk diffusion susceptibility testing revealed that the most frequently detected resistance was to tetracycline (92.2%), followed by nalidixic acid (75.6%), ciprofloxacin (65.0%), azithromycin (41.5%), ampicillin (33.3%), and streptomycin (26.1%). Of the C. jejuni and C. coli isolates, 65.7% (n=109) contained plasmids carrying the tet(O) gene. Six C. jejuni isolates and two C. coli isolates with high-level resistance to tetracycline (MIC=256 microg/ml) harbored the tet(O) plasmid, which is transferable to other C. jejuni and C. coli isolates. These results demonstrate the presence of an interspecies transferable plasmid containing the tet(O) gene and a high prevalence of antibiotic resistance in Korean Campylobacter isolates and provide an understanding of the antibiotic resistance distribution among Campylobacter species in Korea.
Subject(s)
Anti-Bacterial Agents/pharmacology , Campylobacter coli/drug effects , Campylobacter jejuni/drug effects , Chickens/microbiology , Drug Resistance, Bacterial , Swine/microbiology , Animals , Bacterial Proteins/genetics , Campylobacter coli/isolation & purification , Campylobacter jejuni/isolation & purification , Carrier Proteins/genetics , Colony Count, Microbial , Consumer Product Safety , Dose-Response Relationship, Drug , Drug Resistance, Bacterial/genetics , Food Contamination/analysis , Food Microbiology , Humans , Korea , Microbial Sensitivity Tests , Plasmids/genetics , Prevalence , Tetracycline Resistance/geneticsABSTRACT
Staphylococcus aureus is a major etiological pathogen of bovine mastitis, which triggers significant economic losses in dairy herds worldwide. In this study, S. aureus strains isolated from the milk of cows suffering from mastitis in Korea were investigated by spa typing and staphylococcal enterotoxin (SE) gene profiling. Forty-four S. aureus strains were isolated from 26 farms in five provinces. All isolates grouped into five clusters and two singletons based on 14 spa types. Cluster 1 and 2 isolates comprised 38.6% and 36.4% of total isolates, respectively, which were distributed in more than four provinces. SE and SE-like toxin genes were detected in 34 (77.3%) isolates and the most frequently detected SE gene profile was seg, sei, selm, seln, and selo genes (16 isolates, 36.3%), which was comparable to one of the genomic islands, Type I nuSabeta. This is a first report of spa types and the prevalence of the recently described SE and SE-like toxin genes among S. aureus isolates from bovine raw milk in Korea. Two predominant spa groups were distributed widely and recently described SE and SE-like toxin genes were detected frequently.
Subject(s)
Enterotoxins/genetics , Mastitis, Bovine/microbiology , Milk/microbiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/isolation & purification , Animals , Cattle , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Enterotoxins/chemistry , Female , Genotype , Mastitis, Bovine/epidemiology , Mastitis, Bovine/genetics , Microsatellite Repeats , Polymerase Chain Reaction/veterinary , Prevalence , Republic of Korea/epidemiology , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcus aureus/classification , Staphylococcus aureus/geneticsABSTRACT
Staphylococcus intermedius is a common cause of otitis externa, pyoderma and wound infections in companion animals. Although S. intermedius infections are rare in humans, it is zoonotic, with several case reports describing fatal human infections. Presently, we sought to isolate S. intermedius strains from various sources at animal hospitals nationwide in Korea, examine their antibiotic susceptibilities, and determine the possibility of horizontal transmission between animals and humans. Pulsed field gel electrophoresis (PFGE) was used to compare the mecA gene in S. intermedius strains from humans, animals and the environment in animal hospitals. A total of 119 S. intermedius strains were isolated from 529 samples. Using the disk-diffusion method over 90% of the isolates were susceptible to cephalothin, amoxicillin-clavulanic acid, vancomycin, imipenem, nitroflurantoin and amikacin, whereas 97.5% and 98.3% of the isolates were resistant to penicillin and ampicillin, respectively. Among the 39 S. intermedius strains harbouring mecA, similar PFGE patterns were observed between seven isolates from an animal, two isolates from veterinary staff and the environment in one animal hospital, and single isolates from an animal and a veterinarian at another hospital. This result suggests the possibility of horizontal transmission of S. intermedius containing mecA between humans, animals and the environment in animal hospitals and also emphasizes on the importance of S. intermedius with mecA as a possible emerging threat to public health.
Subject(s)
Bacterial Proteins/genetics , Dog Diseases/microbiology , Gene Transfer, Horizontal , Staphylococcal Infections/microbiology , Staphylococcal Infections/veterinary , Staphylococcus/genetics , Zoonoses/transmission , Animals , Bacterial Proteins/metabolism , Dog Diseases/transmission , Dogs , Drug Resistance, Multiple, Bacterial , Health Personnel , Hospitals, Animal , Humans , Microbial Sensitivity Tests , Staphylococcal Infections/transmission , Staphylococcus/drug effects , Staphylococcus/metabolism , Zoonoses/microbiologyABSTRACT
Equine respiratory disease is a common cause of poor performance and training interruptions. The higher incidence rate of infectious upper respiratory disease (IURD) in thoroughbred racehorses at the Seoul Race Park coincided with the frequent stabling season, shorter stabling periods, and younger ages in this study. Incidence rates were also correlated with significantly lower proportions of cells expressing MHC class II-, CD2 antigen-, CD4+- or CD8+-T lymphocyte-, and B lymphocyte in IURD patients compared with healthy control groups in the summer and fall and in 2-and-3-year-old groups. The data suggested that movement and new environments may have resulted in immunosuppression and inappropriate responses to respiratory pathogens in IURD patients. The IURD incidence decreased with age, perhaps by the acquisition of immunity, and study results suggested that immunologic protection was associated with IURD, particularly in young thoroughbred racehorses. Streptococci isolates were identified in 11 of 72 IURD horses, and 3 of these isolates were identified as Streptococcus. equi subsp. equi. S. equi subsp. zooepidemicus was isolated from 2 of 23 IURD horses in the spring (8.7%), 5 of 23 in the summer (21.7%), and 1 of 6 in winter (16.7%). S. equi subsp. zooepidemicus (5%) was also identified in 3 of 61 isolates from clinically normal horses. Racetracks should implement anti-IURD protective measures by assessing the capacity of equine immunologic protection at the Park and by limiting the introduction of specific respiratory pathogens (such as S. equi subsp. equi) by preventing the access of infected horses with a respiratory pathogen-free certification system prior to Park entry.
Subject(s)
Horse Diseases/etiology , Horse Diseases/microbiology , Respiratory Tract Infections/veterinary , Streptococcal Infections/veterinary , Streptococcus equi/isolation & purification , Animals , Anti-Bacterial Agents/therapeutic use , DNA Primers , Environment , Genetic Predisposition to Disease , Horse Diseases/drug therapy , Horse Diseases/immunology , Horses , Korea , Microbial Sensitivity Tests , Polymerase Chain Reaction/methods , Reference Values , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/etiology , Respiratory Tract Infections/immunology , Streptococcal Infections/drug therapy , Streptococcal Infections/etiology , Streptococcal Infections/immunology , Streptococcus equi/drug effects , Streptococcus equi/geneticsABSTRACT
Adipose tissue-derived mesenchymal stem cells (AD-MSCs), which can differentiate into several lineages, have immunomodulatory properties similar to those of bone marrow-derived MSCs. However, the specific mechanism by which the immunomodulatory effect of MSCs occurs is not clear. In this study, we isolated canine AD-MSCs (cAD-MSCs) and induced their development into adipocyte, osteocyte, and neuron-like cells. We then investigated their phenotype and cytokine expression to determine whether they were able to exert an immunomodulatory effect and what the underlying mechanisms of this effect were. cAD-MSCs expressed CD44, CD90, and MHC class I and were also partially positive for the expression of CD34; however, they did not express CD14 and CD45. In addition, they expressed the mRNA of transforming growth factor beta (TGF-beta), IL-6, IL-8, CCL2, CCL5, vascular endothelial growth factor, hepatocyte growth factor (HGF), tissue inhibitor metalloproteinase-1/2, and cyclooxygenase-2 but not that of IL-10. Further, leukocyte proliferation induced by mitogens was suppressed when they were cocultured with irradiated cAD-MSCs, as well as with culture supernatants of cAD-MSCs alone. Moreover, TNF-alpha production significantly decreased, whereas TGF-beta, IL-6, and interferon-gamma production significantly increased in cAD-MSCs that were cocultured with leukocytes. Finally, immonomodulatory factors of MSCs, such as TGF-beta, HGF, prostaglandin E2 (PGE2), and indoleamine 2, 3 dioxygenase (IDO), increased significantly in cAD-MSCs that were cocultured with leukocytes; however, the production of PGE2 and IDO showed different kinetics, and leukocyte proliferation was effectively restored by PGE2 and IDO inhibitors. Taken together, these results indicate that the immunomodulatory effects of cAD-MSCs are associated with soluble factors (TGF-beta, HGF, PGE2, and IDO). Therefore, it is suggested that cAD-MSCs have a potential therapeutic use in the treatment of immune-mediated disease.
Subject(s)
Adipose Tissue/immunology , Cell Proliferation , Gene Expression Regulation/immunology , Leukocytes/immunology , Mesenchymal Stem Cells/immunology , Adipose Tissue/cytology , Adipose Tissue/metabolism , Animals , Antigens, CD/biosynthesis , Antigens, CD/immunology , Cell Separation/methods , Coculture Techniques , Cyclooxygenase 2/biosynthesis , Cyclooxygenase 2/immunology , Cytokines/biosynthesis , Cytokines/immunology , Dinoprostone/immunology , Dinoprostone/metabolism , Dogs , Histocompatibility Antigens Class I/biosynthesis , Histocompatibility Antigens Class I/immunology , Indoleamine-Pyrrole 2,3,-Dioxygenase/biosynthesis , Indoleamine-Pyrrole 2,3,-Dioxygenase/immunology , Leukocytes/cytology , Leukocytes/metabolism , Mesenchymal Stem Cell Transplantation/methods , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/immunology , Tissue Inhibitor of Metalloproteinase-1/biosynthesis , Tissue Inhibitor of Metalloproteinase-1/immunology , Tissue Inhibitor of Metalloproteinase-2/biosynthesis , Tissue Inhibitor of Metalloproteinase-2/immunologyABSTRACT
OBJECTIVE: Our previous study has shown that granulocyte-macrophage colony-stimulating factor (GM-CSF) gene/silica nanoparticles have a leukocytosis effect in normal dogs. Therefore, this study was conducted to determine whether treatment of canine GM-CSF gene/silica nanoparticles has preventive or therapeutic effects in dogs with leukopenia. MATERIALS AND METHODS: To induce leukopenia, vinblastine was administered intravenously at a dose of 2 mg/m(2) of body surface area on day 0. Then 7.5 microg GM-CSF/nanoparticles (1:100, w/w) were administered intravenously to each of four dogs in the prevention group on day 2 and an equivalent amount of GM-CSF/nanoparticles was administered to the post-nadir group on day 4 (other groups were administered phosphate-buffered saline intravenously). RESULTS: Therapeutic GM-CSF gene was expressed in peripheral blood mononuclear cells for 10 days and both the prevention and post-nadir groups showed significant increases in white blood cell counts when compared with the control group, as confirmed by complete blood count, differential count, and flow cytometry. CONCLUSIONS: GM-CSF/nanoparticles can be useful for correction of acute leukopenia, such as chemotherapy-induced myelosuppression, without developing neutralizing antibodies.
Subject(s)
Genetic Therapy/methods , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Leukocytes/pathology , Leukopenia/therapy , Leukopoiesis , Animals , Blood Cell Count , Cytomegalovirus/genetics , DNA, Recombinant/administration & dosage , DNA, Recombinant/therapeutic use , Dogs , Drug Carriers , Genes, Synthetic , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Isoantibodies/biosynthesis , Leukopenia/blood , Leukopenia/chemically induced , Nanoparticles , Promoter Regions, Genetic , Silicon Dioxide , Simian virus 40/genetics , Transcription, Genetic , Vinblastine/toxicityABSTRACT
OBJECTIVE: We sought to test two concepts: that nanoparticles can be used for in vivo gene delivery and that canine granulocyte-macrophage colony-stimulating factor (GM-CSF)/nanoparticles can have possibility to be used to treat transient (acute) canine leukopenia. MATERIALS AND METHODS: We have generated a novel fluorescent-silica nanoparticle binding of canine GM-CSF gene; canine GM-CSF gene was inserted between the cytomegalovirus promoter and poly-adenylation sequences of simian virus 40, and the gene construct was ligated to fluorescent silica nanoparticles functionalized with tertiary amine. RESULTS: When the GM-CSF/nanoparticles were injected into normal dogs, the GM-CSF was expressed in peripheral blood mononuclear cells for at least 9 days and there were significant increases in white blood cell counts, as confirmed by complete blood count, differential count, and flow cytometry. Significant increases in expression of major histocompatibility complex class II on granulocytes and in serum GM-CSF were also observed. Readministration of the nanoparticles was also effective and expression in various tissues was confirmed by reverse transcriptase polymerase chain reaction. CONCLUSIONS: These GM-CSF/nanoparticles may be useful for correction of acute leukopenia, such as chemotherapy-induced myelosuppression without developing neutralizing antibodies.
Subject(s)
Gene Transfer Techniques , Genetic Therapy , Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Leukopenia/therapy , Nanoparticles , Silicon Dioxide/pharmacology , Acute Disease , Animals , Dogs , Gene Expression/genetics , Gene Expression Regulation/genetics , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Granulocytes/metabolism , Histocompatibility Antigens Class II/biosynthesis , Histocompatibility Antigens Class II/genetics , Leukocytes, Mononuclear/metabolism , Leukopenia/genetics , Leukopenia/metabolismABSTRACT
Staphylococcus aureus is one of the main etiological agents of bovine mastitis; however, antibiotics that are effective against bovine strains of S. aureus are not currently available. Staphylococcal enterotoxin type C (SEC), a superantigen, is the enterotoxin most frequently expressed by bovine strains of S. aureus and one of immunogenic determinants. The purpose of this study was to evaluate the protective effectiveness of recombinant SEC mutant vaccine (MastaVactrade mark) against experimentally induced bovine infection. Three representative SEC secreting strains were selected from 9 candidate isolates that showed various intensities of pathogenicity on mice and inoculated into 5 lactating dairy cattle at a concentration of 50-5.0x10(8) CFU per quarter. The optimal experimental bovine subclinical mastitis model was produced by inoculation with 50 CFU of S. aureus 409 per quarter, a level which was not lethal to mice. After the experimental model was determined, other 3 cattle were intramuscularly administered three doses of vaccine at day 0, at 2 wks and at 6 wks. Nine quarters of 3 vaccinated cattle and 8 quarters of 3 control cattle were then challenged with S. aureus 409. An SEC-specific ELISA test conducted at 4 wks post-immunization confirmed the presence of a high antibody titer against SEC in all vaccinated cattle. The somatic cell counts from the vaccinated group remained relatively low, whereas those of control group increased significantly after challenge with S. aureus. After challenge, S. aureus was not isolated from any cattle in the vaccinated group, whereas it was isolated from 75% of the cattle in the control group. These results indicate that recombinant SEC mutant vaccine had a protective effect against S. aureus intramammary infection in lactating cattle.
Subject(s)
Enterotoxins/administration & dosage , Mastitis, Bovine/microbiology , Staphylococcal Infections/prevention & control , Staphylococcal Infections/veterinary , Staphylococcus aureus/isolation & purification , Animals , Antibodies, Bacterial/analysis , Antibodies, Bacterial/immunology , Cattle , Dairying , Enterotoxins/genetics , Enterotoxins/immunology , Staphylococcal Infections/immunology , Staphylococcus aureus/genetics , Staphylococcus aureus/immunology , Staphylococcus aureus/pathogenicity , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunologyABSTRACT
The antibacterial effect and mechanism of action of a silver ion solution that was electrically generated were investigated for Staphylococcus aureus and Escherichia coli by analyzing the growth, morphology, and ultrastructure of the bacterial cells following treatment with the silver ion solution. Bacteria were exposed to the silver ion solution for various lengths of time, and the antibacterial effect of the solution was tested using the conventional plate count method and flow cytometric (FC) analysis. Reductions of more than 5 log(10) CFU/ml of both S. aureus and E. coli bacteria were confirmed after 90 min of treatment with the silver ion solution. Significant reduction of S. aureus and E. coli cells was also observed by FC analysis; however, the reduction rate determined by FC analysis was less than that determined by the conventional plate count method. These differences may be attributed to the presence of bacteria in an active but nonculturable (ABNC) state after treatment with the silver ion solution. Transmission electron microscopy showed considerable changes in the bacterial cell membranes upon silver ion treatment, which might be the cause or consequence of cell death. In conclusion, the results of the present study suggest that silver ions may cause S. aureus and E. coli bacteria to reach an ABNC state and eventually die.
Subject(s)
Anti-Bacterial Agents/pharmacology , DNA, Bacterial/drug effects , Escherichia coli/drug effects , Silver Nitrate/pharmacology , Silver/pharmacology , Staphylococcus aureus/drug effects , Cell Membrane/drug effects , Cell Membrane/ultrastructure , DNA, Bacterial/analysis , Escherichia coli/chemistry , Escherichia coli/ultrastructure , Microscopy, Electron, Transmission , Silver/analysis , Staphylococcus aureus/physiologyABSTRACT
Staphylococcal food poisoning is caused by enterotoxin-producing Staphylococcus aureus. We investigated the prevalence of such organisms in samples of bovine mastitic milk (n = 714), raw meat (n = 139), and vegetables (n = 616). We determined the degrees of relatedness of isolates as indicated by antibiogram, staphylococcal enterotoxin (SE) productivity, and coagulase gene restriction fragment length polymorphism analysis. We examined 297 S. aureus isolates and found SE production in 57 (31.8%), 4 (7.8%), and 49 (73.1%) isolates from raw milk, raw meat, and vegetables, respectively. A high proportion of the isolates obtained from milk produced more than two types of toxins (mainly SEA, SEB, and/or SEC), whereas isolates from raw meat and vegetables primarily produced SEA alone. Most isolates were sensitive to cephalothin (97.6%), gentamicin (80.8%), erythromycin (79.5%), and tetracycline (72.7%), but were resistant to penicillin (90.2%) and ampicillin (88.9%). The proportion of antibiotic-resistant isolates differed according the source of the bacteria; the milk and vegetable isolates were more resistant to penicillin and ampicillin than were the meat isolates (P < 0.05), whereas tetracycline resistance was limited to the milk and vegetables isolates. The coagulase genotypes (I to XII) varied with the source of the organism, and only a few genotypes prevailed in each source: II (42.4%) and IV (24%) types in isolates from milk, IX (35.3%) and XI (45%) from raw meat, and III (40.3%) and XII (32.8%) from vegetables. These findings suggest that remarkable differences exist in antibiogram, SE productivity, and coagulase genotypes, resulting in limited clonal transmission of S. aureus into various food sources. As enterotoxin production only occurs when S. aureus grows to high numbers, staphylococcal food poisoning can be prevented by proper refrigeration.
Subject(s)
Anti-Bacterial Agents/pharmacology , Coagulase/metabolism , Enterotoxins/biosynthesis , Food Contamination/analysis , Food Handling/methods , Staphylococcus aureus/isolation & purification , Animals , Cattle , Coagulase/genetics , Consumer Product Safety , Drug Resistance, Bacterial , Female , Food Contamination/prevention & control , Genotype , Humans , Korea , Meat/microbiology , Microbial Sensitivity Tests , Milk/microbiology , Polymorphism, Restriction Fragment Length , Refrigeration , Staphylococcal Food Poisoning/prevention & control , Staphylococcus aureus/drug effects , Staphylococcus aureus/enzymology , Staphylococcus aureus/metabolism , Vegetables/microbiologyABSTRACT
Campylobacter species are one of the most common causes of bacterial diarrhea in humans worldwide. The consumption of foods contaminated with two Campylobacter species, C. jejuni and C. coli, is usually associated with most of the infections in humans. In this study, a rapid, reliable, and sensitive multiplex real-time quantitative PCR was developed for the simultaneous detection, identification, and quantification of C. jejuni and C. coli. In addition, the developed method was applied to the 50 samples of raw chicken meat collected from retail stores in Korea. C. jejuni and C. coli were detected in 88 and 86% of the samples by real-time quantitative PCR and the conventional microbiological method, respectively. The specificity of the primer and probe sets was confirmed with 30 C. jejuni, 20 C. coli, and 35 strains of other microbial species. C. jejuni and C. coli could be detected with high specificity in less than 4 h, with a detection limit of 1 log CFU/ml by the developed real-time PCR. The average counts (log CFU per milliliter) of C. jejuni or C. coli obtained by the conventional methods and by the real-time PCR assay were statistically correlated with a correlation coefficient (R2) between 0.73 and 0.78. The real-time PCR assay developed in this study is useful for screening for the presence and simultaneous differential quantification of C. jejuni and C. coli.
Subject(s)
Campylobacter coli/isolation & purification , Campylobacter jejuni/isolation & purification , Food Contamination/analysis , Meat/microbiology , Polymerase Chain Reaction/methods , Animals , Chickens , Colony Count, Microbial , Food Microbiology , Humans , Risk Assessment , Sensitivity and Specificity , Species Specificity , Time FactorsABSTRACT
An anti-fungal efficacy test of the silver laundry machine, which electrically generates silver ions, was carried out against four fungi--Trichophyton rubrum, Candida albicans, Microsporum canis and Aspergillus flavus--which cause major fungal infection in humans and animals. Compared with the conventional laundry machine, washing with the silver laundry machine regardless of detergent use was effective against most of the fungi with about 4 log(10) (CFU ml(-1)) reduction and eliminated almost all the fungi when using the detergent. Moreover, the cleaning activity of the silver laundry machine with detergent was higher than that of the conventional laundry machine with detergent both after wash and after final spin step against all four examined fungi. The silver laundry machine may be useful in preventing skin irritation caused by fungi-contaminated fabric in the hospital and in the home.